REPORTS

Let’s Pullulate and Expand Your Business

Female Contraception Drug Market - Global Professional Analysis and Forecast to 2026

Apr 02, 2020  |  166 PAGES  |  REPORT CODE: CMM275100
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Female Contraception Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.3% during the forecast period.

This report presents the market size and development trends by detailing the Female Contraception Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Female Contraception Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Female Contraception Drug industry and will help you to build a panoramic view of the industrial development.

Female Contraception Drug Market, By Type:

  • AG-890

  • Amphora

  • BAY-1007626

  • Drospirenone

  • Others

Female Contraception Drug Market, By Application:

  • Clinic

  • Hospital

  • Homecare

Some of the leading players are as follows:

  • Orbis Biosciences Inc

  • Teva Pharmaceutical Industries Ltd

  • Bayer AG

  • Mithra Pharmaceuticals SA

  • Hervana Ltd

  • Agile Therapeutics Inc

  • Addex Therapeutics Ltd

  • Viramal Ltd

  • Evofem Inc

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Female Contraception Drug Market: Technology Type Analysis

  • 4.1 Female Contraception Drug Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Female Contraception Drug Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 AG-890

    • 4.3.2 Amphora

    • 4.3.3 BAY-1007626

    • 4.3.4 Drospirenone

    • 4.3.5 Others

5 Female Contraception Drug Market: Product Analysis

  • 5.1 Female Contraception Drug Product Market Share Analysis, 2018 & 2026

  • 5.2 Female Contraception Drug Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Female Contraception Drug Market: Application Analysis

  • 6.1 Female Contraception Drug Application Market Share Analysis, 2018 & 2026

  • 6.2 Female Contraception Drug Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Clinic

    • 6.3.2 Hospital

    • 6.3.3 Homecare

7 Female Contraception Drug Market: Regional Analysis

  • 7.1 Female Contraception Drug Regional Market Share Analysis, 2018 & 2026

  • 7.2 Female Contraception Drug Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Orbis Biosciences Inc

    • 9.1.1 Orbis Biosciences Inc Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Teva Pharmaceutical Industries Ltd

    • 9.2.1 Teva Pharmaceutical Industries Ltd Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Bayer AG

    • 9.3.1 Bayer AG Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Mithra Pharmaceuticals SA

    • 9.4.1 Mithra Pharmaceuticals SA Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Hervana Ltd

    • 9.5.1 Hervana Ltd Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Agile Therapeutics Inc

    • 9.6.1 Agile Therapeutics Inc Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Addex Therapeutics Ltd

    • 9.7.1 Addex Therapeutics Ltd Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Viramal Ltd

    • 9.8.1 Viramal Ltd Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Evofem Inc

    • 9.9.1 Evofem Inc Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

 

The List of Tables and Figures (Totals 109 Figures and 138 Tables)

  • Figure AG-890 Female Contraception Drug market, 2015 - 2026 (USD Million)

  • Figure Amphora Female Contraception Drug market, 2015 - 2026 (USD Million)

  • Figure BAY-1007626 Female Contraception Drug market, 2015 - 2026 (USD Million)

  • Figure Drospirenone Female Contraception Drug market, 2015 - 2026 (USD Million)

  • Figure Others Female Contraception Drug market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Homecare market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Female Contraception Drug market, by country, 2015 - 2026 (USD Million)

  • Table North America Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table North America Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table North America Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Canada Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Canada Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Europe Female Contraception Drug market, by country, 2015 - 2026 (USD Million)

  • Table Europe Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Europe Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Europe Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Germany Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Germany Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table France Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table France Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Italy Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Italy Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Spain Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Spain Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Female Contraception Drug market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table China Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table China Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Japan Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Japan Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table India Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table India Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Female Contraception Drug market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table MEA Female Contraception Drug market, by country, 2015 - 2026 (USD Million)

  • Table MEA Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table MEA Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table MEA Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Female Contraception Drug market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Female Contraception Drug market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Female Contraception Drug market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Orbis Biosciences Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceutical Industries Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mithra Pharmaceuticals SA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hervana Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agile Therapeutics Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Addex Therapeutics Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Viramal Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Evofem Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top